TITLE

12 DOZ. DAILY: Cookie sales cooking at Amgen

PUB. DATE
March 2001
SOURCE
FoodService Director;03/15/2001, Vol. 14 Issue 3, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Introduces the Otis Spunkmeyer cookies offered at Amgen Inc. How to order for the cookies in advance; Remarks from Gina Lougee, general manager of Sodexho Marriott Services; Details on the packaging of the cookies.
ACCESSION #
4281358

 

Related Articles

  • Amgen plays for time. Gershon, D. // Nature;4/26/1990, Vol. 344 Issue 6269, p800 

    Reports on the latest legal issues concerning the United States rights to erythropoietin between Amgen and Genetics Institute. Victory for Amgen over cross-licensing agreements; Genetics Institute unable to find a loophole for its drug, Epogen.

  • Cross-licensing ordered. Gershon, D. // Nature;3/22/1990, Vol. 344 Issue 6264, p278 

    Reports that a United States district court in Boston has ordered Amgen, Inc. and Genetics Institute to license to each other their respective versions of erythropoietin. Agreements will be royalty-free; Two companies will be allowed to compete and to pursue the patent dispute in the federal...

  • Amgen to spend $80 million to create Canadian institute. Gershon, Diane // Nature;3/18/1993, Vol. 362 Issue 6417, p194 

    Reports that a Canadian subsidiary of Amgen Inc. will spend C$100 million over the next ten years to create a medical research institute in Toronto that will study the human immune system and how it relates to diseases such as cancer. Amgen Institute; Ontario Cancer Institute/Princess Margaret...

  • HOW TO KEEP THAT FAMILY FEELING. Erdman, A. // Fortune;4/6/1992, Vol. 125 Issue 7, p95 

    Reports that signs of hypergrowth are everywhere at Amgen, the Thousand Oaks, California, biotechnological firm. Annual growth rate statistics; Reliance of the use of a team system for management; Revenues; Net profit; Total return to investors.

  • Amgen's Epogen sales may drop slightly, but its obesity drug shows promise.  // Medical Marketing & Media;Aug97, Vol. 32 Issue 8, p27 

    Reports on developments at Amgen Inc. Effects of the policy change in Medicare by the US Health Care Financing Administration on its drug Epogen; Progress on the company's Leptin obesity drug.

  • Little minnows grow up to be very big fish. Johnsson, Julie // Crain's Chicago Business;06/01/98, Vol. 21 Issue 22, pA149 

    Focuses on problems encountered by California-based Amgen Incorporated after building an Interferon laboratory in Chicago, Illinois. Details on the financial problems of the company with Continental Bank; Information on the success of Amgen after its relocation to California.

  • Amgen seeks corporate partner for research in inflammation.  // Medical Marketing & Media;Oct97, Vol. 32 Issue 10, p20 

    Reports on Amgen's plan to seek a corporate partner for its inflammation research and development program, headquartered in Boulder, Colorado.

  • Amgen: Genesis on wall street. Panchapakesan, Meenakshi // FW;1/4/94, Vol. 163 Issue 1, p18 

    Presents information about Amgen. Situation with Wall Street; Background information; Opinions; Advantages of Amgen.

  • Amgen reports rise in first quarter results.  // Chemical Market Reporter;05/04/98, Vol. 253 Issue 18, p15 

    Reports on Amgen Inc.'s net income and total revenues or the first quarter of 1998.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics